11 May 2021
13:05 E.S.T.

Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T

Read more

06 May 2021
14:28 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021

Read more

26 Apr 2021
15:06 E.S.T.

Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021

Read more

09 Apr 2021
00:00 E.S.T.

Cellectis Completes Sale of $47 million through its ATM program

Read more

29 Mar 2021
14:48 E.S.T.

Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq

Read more

04 Mar 2021
14:59 E.S.T.

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results

Read more